Back to 
Dimensional Fund Advisors LP
Dimensional Fund Advisors LP
LYEL
3 quarters
Position history for Dimensional Fund Advisors LP's holdings in Lyell Immunopharma, Inc.
Yes. Dimensional Fund Advisors holds 46,434 shares of LYEL (Lyell Immunopharma), worth $454,248, as of its Q3 2026 13F filing. It reduced the position by 21,881 shares (-32.0%) from Q2 2026. Dimensional Fund Advisors has held LYEL since Q1 2026, across 3 quarterly 13F filings.
Current Value
$454,248
Current Shares
46,434
Total Value Change
-$504,751
Total Shares Change
-1,454
Quarter-by-Quarter History
Other major holders of LYEL: Vanguard Group Inc., Vanguard Capital Management LLC, BlackRock, Inc.